BR9813811A - "pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only a single surfactant" - Google Patents

"pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only a single surfactant"

Info

Publication number
BR9813811A
BR9813811A BR9813811-1A BR9813811A BR9813811A BR 9813811 A BR9813811 A BR 9813811A BR 9813811 A BR9813811 A BR 9813811A BR 9813811 A BR9813811 A BR 9813811A
Authority
BR
Brazil
Prior art keywords
micelles
pharmaceutical compositions
pharmaceutical composition
single surfactant
treatment
Prior art date
Application number
BR9813811-1A
Other languages
Portuguese (pt)
Inventor
Gabrielle Sjoequist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR9813811A publication Critical patent/BR9813811A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<B>"COMPOSIçõES FARMACêUTICAS COMPREENDENDO MICELAS QUE COMPREENDEM GLICOCORTICOSTEROìDE LIPOFìLICO E APENAS UM úNICO TENSOATIVO"<D>. A presente invenção se refere a uma composição farmacêutica que compreende micelas em um meio aquoso, em que as micelas compreendem um glicocorticosteróide lipofílico e apenas um único tensoativo farmaceuticamente aceitável. A invenção se refere ainda a um processo para preparação da composição farmacêutica e o uso da composição farmacêutica na fabricação de um medicamento para tratamento de doenças alérgicas e/ou inflamatórias no trato respiratório ou para tratamento de doenças intestinais e a métodos para tratamento de doenças em mamíferos, inclusive o homem.<B> "PHARMACEUTICAL COMPOSITIONS UNDERSTANDING MICELLAS THAT UNDERSTAND LIPOPHYLIC GLYCOCORTICOSTEROID AND JUST A SINGLE SURFACTANT" <D>. The present invention relates to a pharmaceutical composition comprising micelles in an aqueous medium, wherein the micelles comprise a lipophilic glucocorticosteroid and only a single pharmaceutically acceptable surfactant. The invention also relates to a process for preparing the pharmaceutical composition and the use of the pharmaceutical composition in the manufacture of a medicament for the treatment of allergic and / or inflammatory diseases in the respiratory tract or for the treatment of intestinal diseases and methods for treating diseases in mammals, including man.

BR9813811-1A 1997-12-22 1998-12-22 "pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only a single surfactant" BR9813811A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (en) 1997-12-22 1997-12-22 New formulation
PCT/SE1998/002426 WO1999032089A1 (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Publications (1)

Publication Number Publication Date
BR9813811A true BR9813811A (en) 2000-10-03

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813811-1A BR9813811A (en) 1997-12-22 1998-12-22 "pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only a single surfactant"

Country Status (20)

Country Link
EP (1) EP1043973A1 (en)
JP (1) JP2001526210A (en)
KR (1) KR20010024789A (en)
CN (1) CN1283106A (en)
AR (1) AR017220A1 (en)
AU (1) AU1993599A (en)
BR (1) BR9813811A (en)
CA (1) CA2315782A1 (en)
EE (1) EE200000388A (en)
HU (1) HUP0102365A3 (en)
ID (1) ID26945A (en)
IL (1) IL136880A0 (en)
NO (1) NO20003220L (en)
NZ (1) NZ505073A (en)
PL (1) PL341361A1 (en)
SE (1) SE9704833D0 (en)
SK (1) SK9532000A3 (en)
TR (1) TR200001977T2 (en)
WO (1) WO1999032089A1 (en)
ZA (1) ZA9811461B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (en) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (en) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
SE0100901D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JPWO2005018607A1 (en) * 2003-08-20 2007-11-01 味の素株式会社 Pharmaceutical formulations with improved solubility
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (en) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 Precursor micelle preparation and its production process
MX349677B (en) 2007-11-13 2017-08-08 Meritage Pharma Inc Corticosteroid compositions.
US20090131386A1 (en) 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
MX2011002688A (en) * 2008-09-12 2011-04-12 Critical Pharmaceuticals Ltd Improvements in the absorption of therapeutic agents across mucosal membranes or the skin.
CN101982168B (en) * 2010-11-02 2012-05-23 山东大学 Quercetin nano-micelle preparation and preparation method thereof
CN102793678B (en) * 2011-05-26 2017-06-30 邓世明 A kind of preparation method of the Docetaxel injection without tween
DE102011108948A1 (en) * 2011-07-29 2013-01-31 Achim Göpferich Aqueous, colloidal solutions of lipophilic substances, in particular drug solutions
JP5456802B2 (en) * 2012-01-23 2014-04-02 株式会社Ｃａｃ Cell migration promoter and transdermal absorbent for wound treatment
WO2015008301A1 (en) * 2013-07-17 2015-01-22 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR102086316B1 (en) * 2019-09-09 2020-03-09 한국콜마주식회사 Cosmetic composition having excellent percutaneous absorption property

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation

Also Published As

Publication number Publication date
AU1993599A (en) 1999-07-12
CA2315782A1 (en) 1999-07-01
TR200001977T2 (en) 2000-12-21
EE200000388A (en) 2002-02-15
SE9704833D0 (en) 1997-12-22
ID26945A (en) 2001-02-22
NZ505073A (en) 2002-09-27
HUP0102365A3 (en) 2002-01-28
CN1283106A (en) 2001-02-07
NO20003220D0 (en) 2000-06-21
WO1999032089A1 (en) 1999-07-01
AR017220A1 (en) 2001-08-22
NO20003220L (en) 2000-08-22
PL341361A1 (en) 2001-04-09
ZA9811461B (en) 1999-06-22
HUP0102365A2 (en) 2001-11-28
KR20010024789A (en) 2001-03-26
JP2001526210A (en) 2001-12-18
EP1043973A1 (en) 2000-10-18
IL136880A0 (en) 2001-06-14
SK9532000A3 (en) 2000-11-07

Similar Documents

Publication Publication Date Title
BR9813811A (en) &#34;pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only a single surfactant&#34;
BR9814118A (en) New composition of matter
PT99597B (en) METHOD FOR THE PREPARATION OF HYDROXAMIC ACID DERIVATIVES THAT INHIBITS LIPOXYGENASE
BR9910066A (en) Fluid pharmaceutical composition that allows the controlled release of at least one active substance, the manufacturing process of a pharmaceutical composition, and the use of a composition
BR0213040A (en) Compound, process for preparing a compound, and method of treating diseases
BRPI9909282A (en) aminocyclohexyl ether compounds and uses thereof.
BRPI0113042B8 (en) compound of the formula or a physiologically acceptable solvate thereof, use thereof, pharmaceutical composition, pharmaceutical formulation, method of treating a human or animal subject with an inflammatory and/or allergic condition, and, process for preparing a compound or a solvate thereof
BR0109729A (en) Use of a combination of an anti-angiogenic agent and an antihypertensive agent, kit for use in producing an anti-angiogenic effect and / or vascular permeability reducing effect in a warm-blooded animal, and method of treating a unhealthy state associated with angiogenesis
BR9907270A (en) Compound, pharmaceutical composition, use of a compound, and, processes for the treatment or prophylaxis of inflammatory diseases, for example, asthma or copd, and for the preparation of a compound
BR0111206A (en) Arylmethylamine derivatives for use as tryptase inhibitors
PE20001032A1 (en) COMPOSITIONS AND METHODS TO TREAT PULMONARY DISEASES
BR9808812A (en) Composition comprising crystalline, finely divided budesonide particles
BR0212455A (en) Compound, pharmaceutical formulation, combination, use of a compound, method for the prophylaxis or treatment of a clinical condition in a mammal, and, process for preparing a compound.
ECSP034883A (en) AMIDAS OF ANTRANILIC ACIDS WITH SIDE CHAIN OF HETEROARILSULFONILO, PROCEDURE FOR THEIR PREPARATION, ITS EMPLOYMENT AS A MEDICINAL OR DIAGNOSTIC AGENT, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM
CO4290417A1 (en) NEW BENZOYLGUANIDINES AS MEDICINES AND THEIR PREPARATION.
MX9303799A (en) DERIVATIVES OF THE VITAMIN D SERIES WITH MODIFICATIONS IN POSITION 20, PROCEDURE FOR ITS PREPARATION, INTERMEDIATE PRODUCTS FOR THIS PROCEDURE, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AS WELL AS THEIR USE FOR THE PROD.
HUP0104410A2 (en) A composition for the prevention and/or treatment of atherosclerosis
BR0109672A (en) Use of zd6126 or a pharmaceutically acceptable salt thereof and one of: a plantin antitumor agent and a taxane, pharmaceutical composition, combination product, kit, and method for producing a vascularly damaging effect on a warm-blooded animal
TR200002078T2 (en) Synthetic polysaccharides, the process for their preparation and pharmaceutical compositions containing them.
PT1124841E (en) PHENYL-ALCENOIL-GUANIDINES A PROCESS FOR PREPARING ITS USE AS MEDICINES OR DIAGNOSTIC MEDIA AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM
BRPI0410623A (en) compound, process for preparing a compound, pharmaceutical composition, and use of a compound
NO965483L (en) Dinucleoside-5 &#39;, 5&#39;-pyrophosphates
DE59604919D1 (en) Monofunctionalized EDTA, DTPA and TTHA derivatives and their use for the preparation of agents for medical diagnosis or therapy
SE9200199L (en) PHARMACEUTICAL COMPOSITION AND ITS USE
BR0210063A (en) Stable composition and use

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.